Unimicron Technology (3037) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
8 Sep, 2025Executive summary
Q2 2025 net sales reached NT$32,466M, up 7.9% sequentially and 15.2% year-over-year for H1 2025.
Net income for Q2 2025 was NT$260M, a sharp decline from NT$924M in Q1 2025 and NT$1,184M for H1 2025, down 73% year-over-year.
Consolidated financial statements for the six months ended June 30, 2025, were reviewed by independent auditors, with no material misstatements identified.
The group operates globally, with major segments in Taiwan and Mainland China, and employs 30,878 people as of June 30, 2025.
Gross margin in Q2 2025 was 13.1%, slightly down from 13.4% in Q1 2025 and significantly lower than 14.7% in H1 2024.
Financial highlights
Six-month revenue was $62,555,577 thousand, up from $54,280,216 thousand year-over-year.
Net profit for the period was $944,151 thousand, down from $4,028,859 thousand year-over-year.
EBITDA for Q2 2025 was NT$5,201M, down from NT$6,157M in Q1 2025; H1 2025 EBITDA was NT$11,358M, down 20% year-over-year.
EPS (basic and diluted) for Q2 2025 was NT$0.02, down from NT$0.60 in Q1 2025 and NT$0.62 for H1 2025, compared to NT$2.65 in H1 2024.
Cash at end of Q2 2025 was NT$46,074M, up from NT$44,143M at end of Q1 2025.
Outlook and guidance
Forward-looking statements highlight risks and uncertainties that may cause actual results to differ materially from projections.
The company continues to monitor the impact of new IFRS standards and expects no significant effect on financial condition.
No significant events after the balance sheet date were reported.
Latest events from Unimicron Technology
- Q4 2025 delivered higher sales, margins, and net income, led by substrate and automotive growth.3037
Q4 202525 Feb 2026 - Net sales up 12% to NT$96.55B, net income down 38%, with new bonds and HK listing planned.3037
Q3 202512 Dec 2025 - Q1 2025 revenue rose 14% year-over-year, but net income and margins declined.3037
Q1 202519 Jun 2025 - Sales up 13.8% in Q3 2024, but net income and margins declined amid expansion efforts.3037
Q3 202413 Jun 2025 - Revenue rose but profit and margins fell due to higher costs and margin pressure.3037
Q2 202413 Jun 2025 - Sales up 11%, net income down 55–58%, dividend proposed, inventory risk persists.3037
Q4 20245 Jun 2025